Bone laser nears trials in UK
This article was originally published in Clinica
Executive Summary
A laser which generates enough energy to cut through bone without damaging surrounding tissue could enter human trials in the UK soon. A team from Manchester University and Hope Hospital, Manchester, UK, have developed an erbium:YAG laser which works at 2.94 micro m, suitable for cutting bone with minimal collateral damage. Research models of the laser have been built but additional funding is required to progress to the clinical stage.
You may also be interested in...
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.